Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) (1) (iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G filed on...Joint Filing Agreement • February 13th, 2004 • Highbridge Capital Corp • Pharmaceutical preparations
In accordance with Rule 13d-1(k) (1) (iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G filed on February 13, 2004 (including amendments thereto) with respect to the common stock of Ligand Pharmaceuticals Incorporated.
